Hamilton set to evaluate new breast cancer screening method

By Haman Mamdouhi 
February 12, 2009

Hamilton has recently been selected by General Electric Healthcare to be the first city in the world to receive new prototype technologies for use in a molecular breast imaging research program for the purpose of breast cancer detection. Hamilton researchers will design and lead clinical trials to evaluate new technologies which use molecular imaging probes that target breast cancer. The new imaging techniques are capable of detecting small tumours which current imaging techniques are liable to missing.

This new imaging technique, named Molecular Imaging, brings hope to women who are at high of risk of breast cancer, yet are limited to more invasive methods of detection with current imaging techniques. John Valliant, CEO and Scientific Director of the Centre for Probe Development and Commercialization at McMaster University explained, “This technology should allow us to see smaller and smaller tumors because we’re imaging them in a very different way.”

To read the full article, click here.